# OnCo record consolidation-therapy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/consolidation-therapy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "consolidation-therapy" ;
  schema:name "Consolidation therapy"@en ;
  schema:alternateName "consolidation"@en, "consolidation chemotherapy"@en, "consolidation immunotherapy"@en, "post-remission therapy"@en, "intensification"@en ;
  schema:description "Treatment given after a good response to kill the cancer cells that are presumably left but cannot be seen, to make the remission last. Durvalumab after chemoradiation for lung cancer is the best-known example."@en ;
  schema:url <https://onco.cc/terms/consolidation-therapy/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Consolidation_therapy> ;
  schema:citation <https://en.wikipedia.org/wiki/Consolidation_therapy> ;
  onco:related <https://onco.cc/terms/induction-therapy/>, <https://onco.cc/terms/maintenance-therapy/>, <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/oligometastatic/> ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:drugs <https://onco.cc/drugs/durvalumab/> ;
  onco:trials <https://onco.cc/trials/pacific/> .